Reaktion #45509

ord-a1656f847d5b4166abc0cb76fd0c498c

Reaktionsgleichung

N[C@@H]1CCCC[C@H]1N
trans-Cyclohexane-1,2-diamine
COc1cc(-c2csc3c(I)cnc(N)c23)ccc1N
3-(4-amino-3-methoxyphenyl)-7-iodothieno[3,2-c]pyridin-4-amine
NC(=O)CN1CCCC1
2-pyrrolidin-1-ylacetamide
O=P([O-])([O-])[O-].[K+].[K+].[K+]
potassium phosphate
CC(=O)O.CC(=O)O.CC(=O)O.COc1cc(-c2csc3c(NC(=O)CN4CCCC4)cnc(N)c23)ccc1N
title compound
CC(=O)O.CC(=O)O.CC(=O)O.COc1cc(-c2csc3c(NC(=O)CN4CCCC4)cnc(N)c23)ccc1N
N-[4-amino-3-(4-amino-3-methoxyphenyl)thieno[3,2-c]pyridin-7-yl]-2-pyrrolidin-1-ylacetamide triacetate salt

Lösungsmittel

Reaktionsbedingungen

Temperatur
110°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeEvacuated under vacuum
  2. 2
    workup.ADDITIONback filled with nitrogen
  3. 3
    SonstigeThe reaction tube was sealed
  4. 4
    SonstigeThe solvent was removed
  5. 5
    Sonstigethe crude product was purified by reverse phase preparative HPLC

Vorschrift

A schlenck tube was charged with 3-(4-amino-3-methoxyphenyl)-7-iodothieno[3,2-c]pyridin-4-amine (199 mg, 0.5 mmol), 2-pyrrolidin-1-ylacetamide (0.6 mmol), copper(I) iodide (4.8 mg, 0.025 mmol), potassium phosphate (225 mg, 1.06 mmol). Evacuated under vacuum and back filled with nitrogen. trans-Cyclohexane-1,2-diamine (6.5 uL, 0.05 mmol) and dioxane (1 mL) was added. The reaction tube was sealed and heated at about 110° C. overnight. The solvent was removed and the crude product was purified by reverse phase preparative HPLC to give the title compound as the tri-acetate salt. LCMS (Conditions a): MH+=398.2, Rt=1.55 min. (154 mg, 45%)

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07737160B2uspto-grants-2010_06